 Monica Federico
Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 19 | 2024 | 2229 | 2.770 |
Why?
| | Social Determinants of Health | 5 | 2024 | 220 | 1.060 |
Why?
| | Virus Diseases | 1 | 2021 | 210 | 0.610 |
Why?
| | Anti-Asthmatic Agents | 2 | 2020 | 374 | 0.600 |
Why?
| | Medication Adherence | 2 | 2020 | 556 | 0.560 |
Why?
| | Patient Discharge | 1 | 2022 | 835 | 0.490 |
Why?
| | Health Status Disparities | 3 | 2024 | 251 | 0.460 |
Why?
| | School Health Services | 2 | 2024 | 233 | 0.360 |
Why?
| | Dexamethasone | 2 | 2019 | 350 | 0.330 |
Why?
| | Urban Population | 2 | 2024 | 441 | 0.310 |
Why?
| | Poverty | 3 | 2019 | 496 | 0.300 |
Why?
| | Child | 15 | 2024 | 20785 | 0.290 |
Why?
| | Healthcare Disparities | 2 | 2024 | 575 | 0.250 |
Why?
| | Anti-Ulcer Agents | 1 | 2005 | 15 | 0.240 |
Why?
| | Health Services Accessibility | 4 | 2024 | 899 | 0.230 |
Why?
| | Severity of Illness Index | 5 | 2024 | 2740 | 0.220 |
Why?
| | Urban Health | 1 | 2003 | 79 | 0.210 |
Why?
| | Humans | 21 | 2024 | 129266 | 0.190 |
Why?
| | Needs Assessment | 1 | 2024 | 359 | 0.190 |
Why?
| | Prednisone | 2 | 2019 | 233 | 0.180 |
Why?
| | Lymphocyte Activation | 1 | 2005 | 1109 | 0.180 |
Why?
| | Societies, Medical | 1 | 2024 | 744 | 0.170 |
Why?
| | Phenotype | 2 | 2021 | 3074 | 0.170 |
Why?
| | Residence Characteristics | 2 | 2020 | 327 | 0.170 |
Why?
| | Frustration | 1 | 2020 | 8 | 0.170 |
Why?
| | Aftercare | 1 | 2022 | 203 | 0.170 |
Why?
| | Respiratory Sounds | 2 | 2021 | 118 | 0.170 |
Why?
| | Nebulizers and Vaporizers | 2 | 2017 | 83 | 0.160 |
Why?
| | Family Relations | 1 | 2020 | 87 | 0.160 |
Why?
| | Pneumonia | 1 | 2005 | 616 | 0.160 |
Why?
| | Housing | 1 | 2020 | 130 | 0.150 |
Why?
| | Biomedical Research | 1 | 2024 | 637 | 0.150 |
Why?
| | Environment | 2 | 2019 | 344 | 0.150 |
Why?
| | Allergens | 1 | 2021 | 385 | 0.150 |
Why?
| | Biomarkers | 2 | 2021 | 3968 | 0.140 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 375 | 0.140 |
Why?
| | Patient Education as Topic | 1 | 2022 | 737 | 0.130 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 76 | 0.130 |
Why?
| | T-Lymphocytes | 1 | 2005 | 1933 | 0.130 |
Why?
| | Cholinergic Antagonists | 1 | 2016 | 29 | 0.130 |
Why?
| | Airway Remodeling | 1 | 2016 | 61 | 0.130 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1209 | 0.120 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1896 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 508 | 0.120 |
Why?
| | Albuterol | 2 | 2017 | 103 | 0.120 |
Why?
| | Glucocorticoids | 2 | 2017 | 578 | 0.120 |
Why?
| | Spirometry | 2 | 2024 | 257 | 0.120 |
Why?
| | Drug Monitoring | 1 | 2016 | 216 | 0.120 |
Why?
| | Prevalence | 2 | 2016 | 2553 | 0.110 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1497 | 0.110 |
Why?
| | Bronchodilator Agents | 2 | 2017 | 243 | 0.110 |
Why?
| | Risk Factors | 4 | 2019 | 9745 | 0.110 |
Why?
| | Smoking | 1 | 2019 | 1499 | 0.090 |
Why?
| | United States | 3 | 2024 | 13826 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1267 | 0.090 |
Why?
| | Adolescent | 6 | 2024 | 20313 | 0.070 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.070 |
Why?
| | Silver | 1 | 2007 | 34 | 0.070 |
Why?
| | Skin Pigmentation | 1 | 2007 | 45 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 2006 | 51 | 0.070 |
Why?
| | Colorado | 3 | 2024 | 4406 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2006 | 105 | 0.060 |
Why?
| | Patient-Centered Care | 1 | 2011 | 505 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2005 | 86 | 0.060 |
Why?
| | Histamine H2 Antagonists | 1 | 2005 | 29 | 0.060 |
Why?
| | Male | 9 | 2024 | 63512 | 0.060 |
Why?
| | Respiratory Hypersensitivity | 1 | 2005 | 64 | 0.060 |
Why?
| | Proton Pump Inhibitors | 1 | 2005 | 100 | 0.050 |
Why?
| | Female | 8 | 2024 | 68551 | 0.050 |
Why?
| | Forced Expiratory Volume | 1 | 2005 | 510 | 0.050 |
Why?
| | Overweight | 1 | 2008 | 531 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2024 | 156 | 0.050 |
Why?
| | Reference Values | 1 | 2005 | 793 | 0.050 |
Why?
| | Interleukins | 1 | 2005 | 241 | 0.050 |
Why?
| | Community-Acquired Infections | 1 | 2005 | 160 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1085 | 0.050 |
Why?
| | Delphi Technique | 1 | 2024 | 225 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2005 | 355 | 0.050 |
Why?
| | Child, Preschool | 3 | 2021 | 10459 | 0.050 |
Why?
| | Hospitalization | 2 | 2021 | 2052 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2011 | 0.040 |
Why?
| | Gene Expression | 1 | 2005 | 1466 | 0.040 |
Why?
| | Pulmonologists | 1 | 2019 | 15 | 0.040 |
Why?
| | Symptom Flare Up | 1 | 2019 | 38 | 0.040 |
Why?
| | Drug Substitution | 1 | 2019 | 51 | 0.040 |
Why?
| | Environmental Exposure | 1 | 2003 | 462 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1584 | 0.040 |
Why?
| | Prospective Studies | 2 | 2024 | 7123 | 0.040 |
Why?
| | Quality of Health Care | 1 | 2003 | 602 | 0.040 |
Why?
| | Health Resources | 1 | 2019 | 113 | 0.040 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 1053 | 0.040 |
Why?
| | Ipratropium | 1 | 2017 | 6 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2005 | 2703 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 768 | 0.030 |
Why?
| | Mass Screening | 1 | 2024 | 1149 | 0.030 |
Why?
| | Disease Progression | 1 | 2024 | 2630 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 271 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 2276 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 615 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1309 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 588 | 0.030 |
Why?
| | Hospitalists | 1 | 2019 | 221 | 0.030 |
Why?
| | Self Report | 1 | 2019 | 795 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1199 | 0.030 |
Why?
| | Clinical Competence | 1 | 2019 | 1016 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3140 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1276 | 0.020 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 113 | 0.020 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2011 | 81 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5736 | 0.020 |
Why?
| | Drug Utilization | 1 | 2011 | 171 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2021 | 14461 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 991 | 0.020 |
Why?
| | Infant | 1 | 2021 | 8975 | 0.020 |
Why?
| | Colloids | 1 | 2007 | 57 | 0.020 |
Why?
| | Complementary Therapies | 1 | 2007 | 87 | 0.020 |
Why?
| | Adult | 2 | 2008 | 35495 | 0.020 |
Why?
| | Aged | 1 | 2005 | 22032 | 0.020 |
Why?
| | Middle Aged | 1 | 2005 | 31090 | 0.010 |
Why?
| | Comorbidity | 1 | 2008 | 1544 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1095 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 3377 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2272 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 5384 | 0.010 |
Why?
|
|
Federico's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|